Home » Autoimmune » Resistance to anti-PD-1 therapy is driven by CD30+ regulatory T cell activity Resistance to anti-PD-1 therapy is driven by CD30+ regulatory T cell activity admin June 11, 2025 Autoimmune SaveSavedRemoved 0 Deal Score0 0 Deal Score0 Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This is a summary of: Lim, J. X. et al. PD-1 receptor deficiency enhances CD30+ Treg cell function in melanoma. Nat. Immunol. (2025). Source link
Added to wishlistRemoved from wishlist 0 The RNA-binding E3 ligase MKRN2 selectively disrupts Il6 translation to restrain inflammation
Added to wishlistRemoved from wishlist 0 Physiological microbial exposure normalizes memory T cell surveillance of the brain and modifies host seizure outcomes
Added to wishlistRemoved from wishlist 0 Cathepsin L-dependent positive selection shapes clonal composition and functional fitness of CD4+ T cells
admin 
